{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:57:32Z","timestamp":1792691852009,"version":"4.5.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04036-7","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T16:14:44Z","timestamp":1769789684000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Design of RGD-functionalized GSH-responsive pegylated polymeric protacs for selective BRD4 degradation and EndMT-driven cardiac fibrosis inhibition"],"prefix":"10.1186","volume":"24","author":[{"given":"Tao","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silong","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongna","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengjin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"9","key":"4036_CR1","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nrd.2016.89","volume":"15","author":"RG Gourdie","year":"2016","unstructured":"Gourdie RG, Dimmeler S, Kohl P. Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease. Nat Rev Drug Discov. 2016;15(9):620\u201338.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"4036_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41569-020-00504-1","volume":"18","author":"B Lopez","year":"2021","unstructured":"Lopez B, Ravassa S, Moreno MU, Jose GS, Beaumont J, Gonzalez A, Diez J. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches. Nat Rev Cardiol. 2021;18(7):479\u201398.","journal-title":"Nat Rev Cardiol"},{"key":"4036_CR3","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148554","author":"JG Travers","year":"2022","unstructured":"Travers JG, Tharp CA, Rubino M, McKinsey TA. Therapeutic targets for cardiac fibrosis: from old school to next-gen. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI148554.","journal-title":"J Clin Invest"},{"issue":"1","key":"4036_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00925-z","volume":"7","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, et al. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther. 2022;7(1):78.","journal-title":"Signal Transduct Target Ther"},{"key":"4036_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1749-6632.2008.03780.x","volume":"1160","author":"XJ Du","year":"2009","unstructured":"Du XJ, Xu Q, Lekgabe E, Gao XM, Kiriazis H, Moore XL, Dart AM, Tregear GW, Bathgate RA, Samuel CS. Reversal of cardiac fibrosis and related dysfunction by relaxin. Ann N Y Acad Sci. 2009;1160:278\u201384.","journal-title":"Ann N Y Acad Sci"},{"issue":"21","key":"4036_CR6","doi-asserted-by":"publisher","first-page":"14843","DOI":"10.1021\/acs.jmedchem.3c01423","volume":"66","author":"T Bi","year":"2023","unstructured":"Bi T, Liang P, Zhou Y, Wang H, Huang R, Sun Q, et al. Rational design of bioorthogonally activatable PROTAC for tumor-targeted protein degradation. J Med Chem. 2023;66(21):14843\u201352.","journal-title":"J Med Chem"},{"issue":"3","key":"4036_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/CIRCULATIONAHA.121.058655","volume":"147","author":"H Tani","year":"2023","unstructured":"Tani H, Sadahiro T, Yamada Y, Isomi M, Yamakawa H, Fujita R, et al. Direct reprogramming improves cardiac function and reverses fibrosis in chronic myocardial infarction. Circulation. 2023;147(3):223\u201338.","journal-title":"Circulation"},{"issue":"11","key":"4036_CR8","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1161\/CIRCRESAHA.110.231910","volume":"107","author":"EM Zeisberg","year":"2010","unstructured":"Zeisberg EM, Kalluri R. Origins of cardiac fibroblasts. Circ Res. 2010;107(11):1304\u201312.","journal-title":"Circ Res"},{"issue":"2","key":"4036_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s40119-020-00199-y","volume":"9","author":"M Webber","year":"2020","unstructured":"Webber M, Jackson SP, Moon JC, Captur G. Myocardial fibrosis in heart failure: anti-fibrotic therapies and the role of cardiovascular magnetic resonance in drug trials. Cardiol Ther. 2020;9(2):363\u201376.","journal-title":"Cardiol Ther"},{"key":"4036_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.697270","volume":"12","author":"G Palano","year":"2021","unstructured":"Palano G, Foinquinos A, Mullers E. In vitro assays and imaging methods for drug discovery for cardiac fibrosis. Front Physiol. 2021;12:697270.","journal-title":"Front Physiol"},{"key":"4036_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00186","volume":"8","author":"L Fang","year":"2017","unstructured":"Fang L, Murphy AJ, Dart AM. A clinical perspective of anti-fibrotic therapies for cardiovascular disease. Front Pharmacol. 2017;8:186.","journal-title":"Front Pharmacol"},{"issue":"11","key":"4036_CR12","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41569-023-00883-1","volume":"20","author":"IA Tamargo","year":"2023","unstructured":"Tamargo IA, Baek KI, Kim Y, Park C, Jo H. Flow-induced reprogramming of endothelial cells in atherosclerosis. Nat Rev Cardiol. 2023;20(11):738\u201353.","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"4036_CR13","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1161\/ATVBAHA.121.313788","volume":"41","author":"Z Alvandi","year":"2021","unstructured":"Alvandi Z, Bischoff J. Endothelial-mesenchymal transition in cardiovascular disease. Arterioscler Thromb Vasc Biol. 2021;41(9):2357\u201369.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4036_CR14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI160517","author":"C Zhou","year":"2023","unstructured":"Zhou C, She X, Gu C, Hu Y, Ma M, Qiu Q, et al. FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/JCI160517.","journal-title":"J Clin Invest"},{"key":"4036_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092338","author":"DB Gurevich","year":"2021","unstructured":"Gurevich DB, David DT, Sundararaman A, Patel J. Endothelial heterogeneity in development and wound healing. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10092338.","journal-title":"Cells"},{"issue":"1","key":"4036_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1042\/BST20200611","volume":"49","author":"AM Clyne","year":"2021","unstructured":"Clyne AM. Endothelial response to glucose: dysfunction, metabolism, and transport. Biochem Soc Trans. 2021;49(1):313\u201325.","journal-title":"Biochem Soc Trans"},{"key":"4036_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jare.2024.01.016","volume":"67","author":"G Li","year":"2025","unstructured":"Li G, Gao J, Ding P, Gao Y. The role of endothelial cell-pericyte interactions in vascularization and diseases. J Adv Res. 2025;67:269\u201388.","journal-title":"J Adv Res"},{"issue":"4","key":"4036_CR18","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.cmet.2020.03.009","volume":"31","author":"K Rohlenova","year":"2020","unstructured":"Rohlenova K, Goveia J, Garcia-Caballero M, Subramanian A, Kalucka J, Treps L, Falkenberg KD, de Rooij L, Zheng Y, Lin L, et al. Single-Cell RNA sequencing maps endothelial metabolic plasticity in pathological angiogenesis. Cell Metab. 2020;31(4):862\u2013e877814.","journal-title":"Cell Metab"},{"key":"4036_CR19","doi-asserted-by":"crossref","unstructured":"Li Z, Xia H, Sharp TE 3rd, LaPenna KB, Katsouda A, Elrod JW, et al. Hydrogen sulfide modulates endothelial-mesenchymal transition in heart failure. Circ Res. 2023;132(2):154\u201366.","DOI":"10.1161\/CIRCRESAHA.122.321326"},{"key":"4036_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116180","author":"A Singh","year":"2024","unstructured":"Singh A, Bhatt KS, Nguyen HC, Frisbee JC, Singh KK. Endothelial-to-mesenchymal transition in cardiovascular pathophysiology. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25116180.","journal-title":"Int J Mol Sci"},{"key":"4036_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-025-01134-1","author":"E Figueroa-Juarez","year":"2025","unstructured":"Figueroa-Juarez E. Tracing the roots of cardiac fibrosis: role of endothelial-to-mesenchymal transition. Nat Rev Cardiol. 2025. https:\/\/doi.org\/10.1038\/s41569-025-01134-1.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"4036_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1074248420952233","volume":"26","author":"W Cheng","year":"2021","unstructured":"Cheng W, Li X, Liu D, Cui C, Wang X. Endothelial-to-mesenchymal transition: role in cardiac fibrosis. J Cardiovasc Pharmacol Ther. 2021;26(1):3\u201311.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"1","key":"4036_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12967-025-06155-5","volume":"23","author":"T Wang","year":"2025","unstructured":"Wang T, Liu B, Huang J, Zhao Q, Shen H, Bi T, et al. IFN-gamma-mediated inhibition of JAK\/STAT signaling via nano-scutellarin treatment is an efficient strategy for ameliorating liver fibrosis. J Transl Med. 2025;23(1):195.","journal-title":"J Transl Med"},{"key":"4036_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaz2597","author":"S Lovisa","year":"2020","unstructured":"Lovisa S, Fletcher-Sananikone E, Sugimoto H, Hensel J, Lahiri S, Hertig A, et al. Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated metabolic reprogramming in kidney fibrosis. Sci Signal. 2020. https:\/\/doi.org\/10.1126\/scisignal.aaz2597.","journal-title":"Sci Signal"},{"issue":"4","key":"4036_CR25","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.apsb.2024.01.012","volume":"14","author":"Y Xing","year":"2024","unstructured":"Xing Y, Hou Y, Fan T, Gao R, Feng X, Li B, et al. Endothelial phosphodiesterase 4B inactivation ameliorates endothelial-to-mesenchymal transition and pulmonary hypertension. Acta Pharm Sin B. 2024;14(4):1726\u201341.","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"4036_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc9465","volume":"9","author":"M Fan","year":"2023","unstructured":"Fan M, Yang K, Wang X, Chen L, Gill PS, Ha T, et al. Lactate promotes endothelial-to-mesenchymal transition via Snail1 lactylation after myocardial infarction. Sci Adv. 2023;9(5):eadc9465.","journal-title":"Sci Adv"},{"issue":"2","key":"4036_CR27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/cas.16045","volume":"115","author":"K Takahashi","year":"2024","unstructured":"Takahashi K, Kobayashi M, Katsumata H, Tokizaki S, Anzai T, Ikeda Y, et al. CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial-mesenchymal transition in tumor microenvironment. Cancer Sci. 2024;115(2):490\u2013506.","journal-title":"Cancer Sci"},{"issue":"7","key":"4036_CR28","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1093\/cvr\/cvac190","volume":"119","author":"Y Yamashiro","year":"2023","unstructured":"Yamashiro Y, Ramirez K, Nagayama K, Hattori N, Liu YY, Matsunaga S, et al. Partial endothelial-to-mesenchymal transition mediated by HIF-induced CD45 in neointima formation upon carotid artery ligation. Cardiovasc Res. 2023;119(7):1606\u201318.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"4036_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06154-0","volume":"7","author":"C Xu","year":"2024","unstructured":"Xu C, Chen J, Liang L, Chen S, Niu X, Sang R, et al. Midkine promotes renal fibrosis by stabilizing C\/EBP\u03b2 to facilitate endothelial-mesenchymal transition. Commun Biol. 2024;7(1):544.","journal-title":"Commun Biol"},{"issue":"10","key":"4036_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05344-0","volume":"13","author":"M Yang","year":"2022","unstructured":"Yang M, Liu K, Chen P, Zhu H, Wang J, Huang J. Bromodomain-containing protein 4 (BRD4) as an epigenetic regulator of fatty acid metabolism genes and ferroptosis. Cell Death Dis. 2022;13(10):912.","journal-title":"Cell Death Dis"},{"key":"4036_CR31","doi-asserted-by":"crossref","unstructured":"White ME, Fenger JM, Carson WE 3rd. Emerging roles of and therapeutic strategies targeting BRD4 in cancer. Cell Immunol. 2019;337:48\u201353.","DOI":"10.1016\/j.cellimm.2019.02.001"},{"issue":"11","key":"4036_CR32","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1021\/acs.jmedchem.6b01761","volume":"60","author":"Z Liu","year":"2017","unstructured":"Liu Z, Wang P, Chen H, Wold EA, Tian B, Brasier AR, et al. Drug discovery targeting Bromodomain-Containing Protein 4. J Med Chem. 2017;60(11):4533\u201358.","journal-title":"J Med Chem"},{"issue":"1","key":"4036_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00641-6","volume":"12","author":"Q Wei","year":"2024","unstructured":"Wei Q, Gan C, Sun M, Xie Y, Liu H, Xue T, et al. BRD4: an effective target for organ fibrosis. Biomark Res. 2024;12(1):92.","journal-title":"Biomark Res"},{"key":"4036_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22116059","author":"T Ijaz","year":"2021","unstructured":"Ijaz T, Burke MA. BET protein-mediated transcriptional regulation in heart failure. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22116059.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4036_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cell.2013.07.013","volume":"154","author":"P Anand","year":"2013","unstructured":"Anand P, Brown JD, Lin CY, Qi J, Zhang R, Artero PC, et al. Bet bromodomains mediate transcriptional pause release in heart failure. Cell. 2013;154(3):569\u201382.","journal-title":"Cell"},{"issue":"6","key":"4036_CR36","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.3892\/etm.2015.2789","volume":"10","author":"Y Sun","year":"2015","unstructured":"Sun Y, Huang J, Song K. Bet protein inhibition mitigates acute myocardial infarction damage in rats via the TLR4\/TRAF6\/NF-kappaB pathway. Exp Ther Med. 2015;10(6):2319\u201324.","journal-title":"Exp Ther Med"},{"issue":"11","key":"4036_CR37","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1097\/TP.0000000000003319","volume":"104","author":"J Chen","year":"2020","unstructured":"Chen J, Miao X, Liu C, Liu B, Wu X, Kong D, et al. Bet protein inhibition prolongs cardiac transplant survival via enhanced myocardial autophagy. Transplantation. 2020;104(11):2317\u201326.","journal-title":"Transplantation"},{"issue":"8038","key":"4036_CR38","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-024-08085-6","volume":"635","author":"M Alexanian","year":"2024","unstructured":"Alexanian M, Padmanabhan A, Nishino T, Travers JG, Ye L, Pelonero A, et al. Chromatin remodelling drives immune cell-fibroblast communication in heart failure. Nature. 2024;635(8038):434\u201343.","journal-title":"Nature"},{"issue":"7","key":"4036_CR39","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/CIRCRESAHA.119.315125","volume":"125","author":"MS Stratton","year":"2019","unstructured":"Stratton MS, Bagchi RA, Felisbino MB, Hirsch RA, Smith HE, Riching AS, et al. Dynamic chromatin targeting of BRD4 stimulates cardiac fibroblast activation. Circ Res. 2019;125(7):662\u201377.","journal-title":"Circ Res"},{"key":"4036_CR40","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c02658","author":"T Bi","year":"2025","unstructured":"Bi T, Liang P, Zhao Q, Wu J, Zhou Y, Xu Y, et al. Targeted degradation of bromodomain-containing protein 4 enabled by reactive oxygen species-activatable nanoprotacs as an efficient strategy to reverse liver fibrosis in chronic liver injury. J Med Chem. 2025. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c02658.","journal-title":"J Med Chem"},{"issue":"1","key":"4036_CR41","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.apsb.2021.07.018","volume":"12","author":"Z He","year":"2022","unstructured":"He Z, Jiao H, An Q, Zhang X, Zengyangzong D, Xu J, et al. Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis. Acta Pharm Sin B. 2022;12(1):291\u2013307.","journal-title":"Acta Pharm Sin B"},{"issue":"24","key":"4036_CR42","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1161\/CIRCULATIONAHA.120.047239","volume":"142","author":"SY Kim","year":"2020","unstructured":"Kim SY, Zhang X, Schiattarella GG, Altamirano F, Ramos TAR, French KM, et al. Epigenetic reader BRD4 (bromodomain-containing protein 4) governs nucleus-encoded mitochondrial transcriptome to regulate cardiac function. Circulation. 2020;142(24):2356\u201370.","journal-title":"Circulation"},{"issue":"4","key":"4036_CR43","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1021\/acs.jmedchem.2c01555","volume":"66","author":"M Li","year":"2023","unstructured":"Li M, Zhi Y, Liu B, Yao Q. Advancing strategies for proteolysis-targeting chimera design. J Med Chem. 2023;66(4):2308\u201329.","journal-title":"J Med Chem"},{"issue":"2","key":"4036_CR44","doi-asserted-by":"publisher","first-page":"e70013","DOI":"10.1002\/wcms.70013","volume":"15","author":"S Tan","year":"2025","unstructured":"Tan S, Chen Z, Lu R, Liu H, Yao X. Rational proteolysis targeting chimera design driven by molecular modeling and machine learning. WIREs Comput Mol Sci. 2025;15(2):e70013.","journal-title":"WIREs Comput Mol Sci"},{"key":"4036_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202508138","author":"Z Chen","year":"2025","unstructured":"Chen Z, Gu C, Tan S, Wang X, Li Y, He M, et al. Interpretable PROTAC degradation prediction with structure-informed deep ternary attention framework. Adv Sci (Weinh). 2025. https:\/\/doi.org\/10.1002\/advs.202508138.","journal-title":"Adv Sci (Weinh)"},{"issue":"14","key":"4036_CR46","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1039\/D2CS00200K","volume":"51","author":"RG Guenette","year":"2022","unstructured":"Guenette RG, Yang SW, Min J, Pei B, Potts PR. Target and tissue selectivity of PROTAC degraders. Chem Soc Rev. 2022;51(14):5740\u201356.","journal-title":"Chem Soc Rev"},{"issue":"3","key":"4036_CR47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M Bekes","year":"2022","unstructured":"Bekes M, Langley DR, Crews CM. PROTAC targeted protein degraders: the past is prologue. Nat Rev Drug Discov. 2022;21(3):181\u2013200.","journal-title":"Nat Rev Drug Discov"},{"issue":"16","key":"4036_CR48","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1039\/D2CS00220E","volume":"51","author":"C Cao","year":"2022","unstructured":"Cao C, He M, Wang L, He Y, Rao Y. Chemistries of bifunctional PROTAC degraders. Chem Soc Rev. 2022;51(16):7066\u2013114.","journal-title":"Chem Soc Rev"},{"issue":"12","key":"4036_CR49","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1039\/D2CS00193D","volume":"51","author":"K Li","year":"2022","unstructured":"Li K, Crews CM. PROTACs: past, present and future. Chem Soc Rev. 2022;51(12):5214\u201336.","journal-title":"Chem Soc Rev"},{"issue":"13","key":"4036_CR50","doi-asserted-by":"publisher","first-page":"8428","DOI":"10.1021\/acs.jmedchem.3c00302","volume":"66","author":"C Chen","year":"2023","unstructured":"Chen C, Yang Y, Wang Z, Li H, Dong C, Zhang X. Recent advances in pro-PROTAC development to address on-target off-tumor toxicity. J Med Chem. 2023;66(13):8428\u201340.","journal-title":"J Med Chem"},{"issue":"6","key":"4036_CR51","doi-asserted-by":"publisher","first-page":"6328","DOI":"10.1021\/acs.jmedchem.4c02658","volume":"68","author":"T Bi","year":"2025","unstructured":"Bi T, Liang P, Zhao Q, Wu J, Zhou Y, Xu Y, et al. Targeted degradation of bromodomain-containing protein 4 enabled by reactive oxygen species-activatable nanoPROTACs as an efficient strategy to reverse liver fibrosis in chronic liver injury. J Med Chem. 2025;68(6):6328\u201338.","journal-title":"J Med Chem"},{"issue":"25","key":"4036_CR52","doi-asserted-by":"publisher","first-page":"14155","DOI":"10.1021\/jacs.3c05159","volume":"145","author":"M Chang","year":"2023","unstructured":"Chang M, Gao F, Pontigon D, Gnawali G, Xu H, Wang W. Bioorthogonal PROTAC prodrugs enabled by on-target activation. J Am Chem Soc. 2023;145(25):14155\u201363.","journal-title":"J Am Chem Soc"},{"issue":"5","key":"4036_CR53","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1021\/jacs.9b12718","volume":"142","author":"Y Naro","year":"2020","unstructured":"Naro Y, Darrah K, Deiters A. Optical control of small molecule-induced protein degradation. J Am Chem Soc. 2020;142(5):2193\u20137.","journal-title":"J Am Chem Soc"},{"issue":"30","key":"4036_CR54","doi-asserted-by":"publisher","first-page":"16642","DOI":"10.1021\/jacs.3c04109","volume":"145","author":"W Wang","year":"2023","unstructured":"Wang W, Zhu C, Zhang B, Feng Y, Zhang Y, Li J. Self-assembled nano-PROTAC enables near-infrared photodynamic proteolysis for cancer therapy. J Am Chem Soc. 2023;145(30):16642\u20139.","journal-title":"J Am Chem Soc"},{"issue":"46","key":"4036_CR55","doi-asserted-by":"publisher","first-page":"18370","DOI":"10.1021\/jacs.9b06422","volume":"141","author":"G Xue","year":"2019","unstructured":"Xue G, Wang K, Zhou D, Zhong H, Pan Z. Light-induced protein degradation with photocaged protacs. J Am Chem Soc. 2019;141(46):18370\u20134.","journal-title":"J Am Chem Soc"},{"issue":"1","key":"4036_CR56","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1021\/jacs.2c10177","volume":"145","author":"C Yang","year":"2023","unstructured":"Yang C, Yang Y, Li Y, Ni Q, Li J. Radiotherapy-triggered proteolysis targeting chimera prodrug activation in tumors. J Am Chem Soc. 2023;145(1):385\u201391.","journal-title":"J Am Chem Soc"},{"key":"4036_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121529","volume":"284","author":"Q Li","year":"2022","unstructured":"Li Q, Huang Z, Wang Q, Gao J, Chen J, Tan H, et al. Targeted immunomodulation therapy for cardiac repair by platelet membrane engineering extracellular vesicles via hitching peripheral monocytes. Biomaterials. 2022;284:121529.","journal-title":"Biomaterials"},{"issue":"3","key":"4036_CR58","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1021\/acs.bioconjchem.2c00439","volume":"34","author":"L Liu","year":"2023","unstructured":"Liu L, Ding W, He L, Yang Y, Guan F, Sun X, et al. RGD and scutellarin conjugate (WK001) targeting platelet glycoprotein IIb\/IIIa receptor protects from myocardial ischemia\/reperfusion injury: synthesis, characterization, and bioactivity evaluation. Bioconjug Chem. 2023;34(3):477\u201388.","journal-title":"Bioconjug Chem"},{"key":"4036_CR59","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg1694","author":"P Zhao","year":"2021","unstructured":"Zhao P, Yao Q, Zhang PJ, The E, Zhai Y, Ao L, et al. Single-cell RNA-seq reveals a critical role of novel pro-inflammatory EndMT in mediating adverse remodeling in coronary artery-on-a-chip. Sci Adv. 2021. https:\/\/doi.org\/10.1126\/sciadv.abg1694.","journal-title":"Sci Adv"},{"issue":"1","key":"4036_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01097-6","volume":"7","author":"H Zeng","year":"2022","unstructured":"Zeng H, Pan T, Zhan M, Hailiwu R, Liu B, Yang H, et al. Suppression of PFKFB3-driven glycolysis restrains endothelial-to-mesenchymal transition and fibrotic response. Signal Transduct Target Ther. 2022;7(1):303.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"4036_CR61","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1002\/ptr.70063","volume":"39","author":"B Zhu","year":"2025","unstructured":"Zhu B, Sun C, Luo D, Liang Y, Jiang A, Jiang Z, et al. Coptisine improves liver inflammation in sepsis by regulating STAT1\/IRF1\/GPX4 signaling-mediated Kupffer cells ferroptosis. Phytother Res. 2025;39(9):4308\u201326.","journal-title":"Phytother Res"},{"issue":"1","key":"4036_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07362-w","volume":"23","author":"B Zhu","year":"2025","unstructured":"Zhu B, Dai X, Liu C, Bi T, Liu S, Chen L, et al. Betulinic acid as a novel AT1R inhibitor: attenuation of liver fibrosis via modulation of endothelial-mesenchymal transition in chronic hepatic injury. J Transl Med. 2025;23(1):1282.","journal-title":"J Transl Med"},{"issue":"2","key":"4036_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202403473","volume":"14","author":"T Bi","year":"2025","unstructured":"Bi T, Zhao Q, Wang T, Huang R, Liu B, Liu X, et al. Disruption of ferroptosis inhibition and immune evasion with tumor-activatable prodrug for boosted photodynamic\/chemotherapy eradication of drug-resistant tumors. Adv Healthc Mater. 2025;14(2):e2403473.","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"4036_CR64","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1021\/jacs.2c13222","volume":"145","author":"W Li","year":"2023","unstructured":"Li W, Yin S, Shen Y, Li H, Yuan L, Zhang XB. Molecular engineering of pH-responsive NIR oxazine assemblies for evoking tumor ferroptosis via triggering lysosomal dysfunction. J Am Chem Soc. 2023;145(6):3736\u201347.","journal-title":"J Am Chem Soc"},{"key":"4036_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116022","author":"PK Chaudhary","year":"2022","unstructured":"Chaudhary PK, Kim S, Kim S. An insight into recent advances on platelet function in health and disease. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23116022.","journal-title":"Int J Mol Sci"},{"key":"4036_CR66","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.copbio.2018.11.010","volume":"58","author":"Y Lu","year":"2019","unstructured":"Lu Y, Hu Q, Jiang C, Gu Z. Platelet for drug delivery. Curr Opin Biotechnol. 2019;58:81\u201391.","journal-title":"Curr Opin Biotechnol"},{"issue":"17","key":"4036_CR67","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.1039\/D3BM00893B","volume":"11","author":"C Yao","year":"2023","unstructured":"Yao C, Wang C. Platelet-derived extracellular vesicles for drug delivery. Biomater Sci. 2023;11(17):5758\u201368.","journal-title":"Biomater Sci"},{"key":"4036_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2024.122058","volume":"334","author":"C Yuan","year":"2024","unstructured":"Yuan C, Ye Y, Hu E, Xie R, Lu B, Yu K, et al. Thrombotic microenvironment responsive crosslinking cyclodextrin metal-organic framework nanocarriers for precise targeting and thrombolysis. Carbohydr Polym. 2024;334:122058.","journal-title":"Carbohydr Polym"},{"issue":"1","key":"4036_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01461-2","volume":"20","author":"C Wang","year":"2022","unstructured":"Wang C, Yang X, Jiang Y, Qi L, Zhuge D, Xu T, et al. Targeted delivery of fat extract by platelet membrane-cloaked nanocarriers for the treatment of ischemic stroke. J Nanobiotechnology. 2022;20(1):249.","journal-title":"J Nanobiotechnology"},{"key":"4036_CR70","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.5c18202","author":"Q Zhao","year":"2025","unstructured":"Zhao Q, Zeng R, Bi T, Yang X, Wang T, Chen L, et al. Synergistic proteolysis targeting chimera chemotherapy conjugate for potent non-small cell lung cancer treatment. ACS Appl Mater Interfaces. 2025. https:\/\/doi.org\/10.1021\/acsami.5c18202.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"7","key":"4036_CR71","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1016\/j.apsb.2022.02.022","volume":"12","author":"S Ma","year":"2022","unstructured":"Ma S, Ji J, Tong Y, Zhu Y, Dou J, Zhang X, et al. Non-small molecule PROTACs (NSM-PROTACs): protein degradation kaleidoscope. Acta Pharm Sin B. 2022;12(7):2990\u20133005.","journal-title":"Acta Pharm Sin B"},{"issue":"25","key":"4036_CR72","doi-asserted-by":"publisher","first-page":"7126","DOI":"10.1016\/j.cell.2024.10.015","volume":"187","author":"P Lu","year":"2024","unstructured":"Lu P, Cheng Y, Xue L, Ren X, Xu X, Chen C, Cao L, Li J, Wu Q, Sun S, et al. Selective degradation of multimeric proteins by TRIM21-based molecular glue and PROTAC degraders. Cell. 2024;187(25):7126\u2013e71427120.","journal-title":"Cell"},{"issue":"9","key":"4036_CR73","doi-asserted-by":"publisher","first-page":"7301","DOI":"10.1021\/acs.jmedchem.4c00152","volume":"67","author":"M Chang","year":"2024","unstructured":"Chang M, Gao F, Gnawali G, Xu H, Dong Y, Meng X, et al. Selective elimination of senescent cancer cells by galacto-modified PROTACs. J Med Chem. 2024;67(9):7301\u201311.","journal-title":"J Med Chem"},{"key":"4036_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116477","volume":"229","author":"S Chen","year":"2024","unstructured":"Chen S, He Q, Yang H, Huang H. Endothelial Birc3 promotes renal fibrosis through modulating Drp1-mediated mitochondrial fission via MAPK\/PI3K\/Akt pathway. Biochem Pharmacol. 2024;229:116477.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"4036_CR75","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41580-018-0081-3","volume":"20","author":"T Narita","year":"2019","unstructured":"Narita T, Weinert BT, Choudhary C. Functions and mechanisms of non-histone protein acetylation. Nat Rev Mol Cell Biol. 2019;20(3):156\u201374.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"4036_CR76","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","volume":"23","author":"M Shvedunova","year":"2022","unstructured":"Shvedunova M, Akhtar A. Modulation of cellular processes by histone and non-histone protein acetylation. Nat Rev Mol Cell Biol. 2022;23(5):329\u201349.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"16","key":"4036_CR77","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1016\/j.molcel.2023.06.032","volume":"83","author":"B Zheng","year":"2023","unstructured":"Zheng B, Gold S, Iwanaszko M, Howard BC, Wang L, Shilatifard A. Distinct layers of BRD4-PTEFb reveal bromodomain-independent function in transcriptional regulation. Mol Cell. 2023;83(16):2896-2910 e2894.","journal-title":"Mol Cell"},{"issue":"51","key":"4036_CR78","doi-asserted-by":"publisher","first-page":"15713","DOI":"10.1073\/pnas.1522163112","volume":"112","author":"N Ding","year":"2015","unstructured":"Ding N, Hah N, Yu RT, Sherman MH, Benner C, Leblanc M, et al. BRD4 is a novel therapeutic target for liver fibrosis. Proc Natl Acad Sci USA. 2015;112(51):15713\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"4036_CR79","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1161\/CIRCULATIONAHA.120.046462","volume":"143","author":"JG Travers","year":"2021","unstructured":"Travers JG, Wennersten SA, Pena B, Bagchi RA, Smith HE, Hirsch RA, et al. HDAC inhibition reverses preexisting diastolic dysfunction and blocks covert extracellular matrix remodeling. Circulation. 2021;143(19):1874\u201390.","journal-title":"Circulation"},{"key":"4036_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116413","volume":"173","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Yang Z, Wang S, Wang X, Mao J. Targeting MAPK-ERK\/JNK pathway: a potential intervention mechanism of myocardial fibrosis in heart failure. Biomed Pharmacother. 2024;173:116413.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"4036_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.525","volume":"5","author":"Q He","year":"2024","unstructured":"He Q, Li J, Tao C, Zeng C, Liu C, Zheng Z, et al. High glutamine increases stroke risk by inducing the endothelial-to-mesenchymal transition in moyamoya disease. MedComm. 2024;5(5):e525.","journal-title":"MedComm"},{"issue":"10","key":"4036_CR82","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1038\/s41401-022-00885-8","volume":"43","author":"K Lin","year":"2022","unstructured":"Lin K, Yang N, Luo W, Qian JF, Zhu WW, Ye SJ, et al. Direct cardio-protection of Dapagliflozin against obesity-related cardiomyopathy via NHE1\/MAPK signaling. Acta Pharmacol Sin. 2022;43(10):2624\u201335.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"4036_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01660-9","volume":"8","author":"J Wan","year":"2023","unstructured":"Wan J, Zhang Z, Wu C, Tian S, Zang Y, Jin G, et al. Astragaloside IV derivative HHQ16 ameliorates infarction-induced hypertrophy and heart failure through degradation of lncRNA4012\/9456. Signal Transduct Target Ther. 2023;8(1):414.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04036-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04036-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04036-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:59:32Z","timestamp":1772024372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04036-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4036"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04036-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}